Speaking on Nyota Tv today morning, Dr. Arthur Ageya outline in depth the Dos and DON’Ts in fighting the monster that has claimed over 39,000 lives in last year across the country.
Among them, the 30 year-old mentioned, was the late diagnosis of cancer cells in human bodies.
“Our biggest threat in fighting this cancer has always been late diagnosis of the condition,” Dr. Ageya told Nyota TV’s Akongo Junior.
According to records, close to 39,000 Kenyans succumb to cancer on annual basis with former Safaricom CEO Bob Collymore, Kibra constituency MP Ken Okoth and Bomet Governor Joyce Labosso the latest high profile figures to tally among the statistics.
However, it’s irritating how the government has only focused on now fighting cancer after the death of senior public figures as if the other 40,000 lives are nothing to attract an eye.
“Cancer cells are beatable if discovered at the very early, reason the government should invest in sensitizing the citizens to go for early screening,” said Dr Ageya who woks with Agha Khan Hospital in Bungoma.
Dr. Ageya also told Nyota TV’s Kikao show that it will still not make sense if many people go for early screening but with no oncologists across the country.
“Even as we advocate for early screening, the government must also ensure that we have enough oncologists (cancer specialists) on the ground to deal with any cases that may arise from the screening”
Kenya is believed to have a paltry 30 oncologists across the country, a sorry figure to handle over 30,000 cases of cancer.
He also urged the media and blogs to highlight cancer success stories across the country to avoid painting the disease as unbeatable.
“We ave several cases of successful treatment on patients. That means that the menace is beatable but the media has not been keen on highlighting such stories as an inspiration to any efforts to fight this cancer.
The show ended with the Doc faulting the move by the government to build new cancer centres countrywide.
“Building new cancer centres will not be enough because that will only mean that most treatment will be on patients in stage four cancer which has very little percentage of survival but early screening and enough manpower will overpower this disease easily and quickly.